Treatment of endometriosis in the presence of varicose disease

V. P. Baskakov; Baskakov V. P.; I. E. Zazerskaya; Zazerskaya I. E.; A. V. Dyachuk; Dyachuk A. V.; A. S. Molodykh; Molodykh A. S.; N. A. Gavrish; Gavrish N. A.; L. A. Shuliko; Shuliko L. A.; D. V. Solomko; Solomko D. V.

doi:10.17816/JOWD100797

Treatment of endometriosis in the presence of varicose disease

Authors: Baskakov V.P.¹^,2, Zazerskaya I.E.¹^,2, Dyachuk A.V.¹^,2, Molodykh A.S.¹^,2, Gavrish N.A.¹^,2, Shuliko L.A.¹^,2, Solomko D.V.¹^,2
Affiliations:
1. Dr. Sokolov Hospital 122
2. I. P. Pavlov State Medical University
Issue: Vol 48, No 5S (1999)
Pages: 39-39
Section: Articles
URL: https://journals.rcsi.science/jowd/article/view/100797
DOI: https://doi.org/10.17816/JOWD100797
ID: 100797

Cite item

Full Text

Abstract
Full Text
About the authors
References
Statistics

Abstract

Complicity of the situation is stipulated by the fact that the overwhelming majority of drugs used for endometriosis treatment cause a shift in the clotting system towards hypercoagulation. Releasing gonadotropines, first of all Zoladex and Decomeptyl-Depo, present an exception to the rule.